IQVIA Holdings Inc., a leader in analytics, technology, and clinical research services, has shown consistent performance. Given its diverse operations across multiple segments, the company's potential for growth remains strong, though market competition is a constant challenge. Investing in IQV could yield positive returns, especially with their innovative solutions aligning with healthcare advancements.
IQV's fundamental rating reflects stable performance across key financial metrics, underscoring its moderate risk profile.
Category | Score | Visual |
---|---|---|
Overall Score | 3 | |
Discounted Cash Flow | 4 | |
Return on Equity | 5 | |
Return on Assets | 5 | |
Debt to Equity | 2 | |
Price to Earnings | 2 | |
Price to Book | 1 |
The scores from previous evaluations indicate stable financial health, though fluctuations reflect market dynamics.
Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-04-24 | 3 | 4 | 5 | 5 | 2 | 2 | 1 |
Previous | 0 | 4 | 5 | 5 | 2 | 2 | 1 |
Analyst targets demonstrate positive outlook and suggest consistent upward potential for IQV's stock price.
High | Low | Median | Consensus |
---|---|---|---|
270 | 235 | 265 | 256.67 |
Analyst sentiment is largely positive, with the majority recommending a 'Buy', signifying strong market confidence.
Recommendation | Count | Visual |
---|---|---|
Strong Buy | 1 | |
Buy | 32 | |
Hold | 7 | |
Sell | 0 | |
Strong Sell | 0 |
IQVIA Holdings Inc. presents a robust investment opportunity, bolstered by a strong presence in the healthcare analytics and research space. Its diversified portfolio allows it to mitigate risks associated with market fluctuations. However, competition and regulatory pressures remain challenges. The company's consistent performance metrics and positive analyst outlooks underscore its potential for future growth. Investors should consider both the opportunities and inherent risks when evaluating IQV's stock.